WISTA
Live / Registered — Cancelled — Section 71 (as of 22 Sept 2023)
What this means for you
Registered since 07 Mar 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79182923
- Registration number
- 5153172
- Mark type
- Stylized text
- Filed
- 22 Dec 2015
- Published for opposition
- 20 Dec 2016
- Registered
- 07 Mar 2017
- Attorney of record
- Thad Chaloemtiarana
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medical preparations for use in the detection, prevention and treatment of neurological diseases and disorders, neurodegenerative diseases and disorders, blood disorders, infectious diseases and malaria; chemical preparations for medical and pharmaceutical purposes for use in the detection, prevention and treatment of neurological diseases and disorders, neurodegenerative diseases and disorders, blood disorders, infectious diseases and malaria; none of the aforesaid being pharmaceutical preparations and substances intended for the prevention and treatment of bone/skeletal diseases
- Class 042 — Scientific and technological services: Medical, biological, biotechnological, genetic, and pharmaceutical research, design and development services and laboratory research services in the fields of drugs, pharmaceuticals and medicines; research, development and design of drugs and medicine; drug discovery services; laboratory and medical laboratory research and development services relating to drugs, pharmaceuticals and medicines; exploitation of scientific research and technology, namely, providing advice and information relating to scientific and technological research in the fields of drugs, pharmaceuticals and medicines, and in the fields of drug development, clinical trial design, patient recruitment, drug testing, clinical data management, data analysis, statistical analysis, patient selection, clinical diagnosis and diagnostic testing; researching and developing new products in the fields of drugs, pharmaceuticals and medicines; scientific research and development services in the fields of drug development, clinical trial design, patient recruitment, drug testing, clinical data management, data analysis, statistical analysis, patient selection, clinical diagnosis and diagnostic testing; preparation of reports of scientific and medical research concerning drugs, pharmaceuticals, medicines, genetics, biology and biotechnology; development and design of medical or scientific prognostic and diagnostic apparatus and instruments; consultancy and information services relating to all of the aforesaid
Owner
- TauRx Therapeutics Ltd., SG
- WisTa Laboratories Ltd, Singapore 658066, SG
- WisTa Laboratories Ltd, Singapore 658066, SG
- WisTa Laboratories Ltd, Singapore 658066, SG
Prosecution history
- 20 Nov 2025 — CHANGE OF OWNER RECEIVED FROM IB
- 14 Jul 2024 — TOTAL INVALIDATION PROCESSED BY THE IB
- 24 Jun 2024 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 24 Jun 2024 — INVALIDATION PROCESSED
- 14 Jun 2024 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 22 Sept 2023 — CANCELLED SECTION 71
- 07 Mar 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 08 Jul 2017 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 19 Jun 2017 — FINAL DISPOSITION NOTICE SENT TO IB
- 19 Jun 2017 — FINAL DISPOSITION PROCESSED
- 07 Jun 2017 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 07 Mar 2017 — REGISTERED-PRINCIPAL REGISTER
- 20 Dec 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Dec 2016 — PUBLISHED FOR OPPOSITION
- 30 Nov 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED